Cargando…
P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430246/ http://dx.doi.org/10.1097/01.HS9.0000847852.69497.6d |
| _version_ | 1784779708257271808 |
|---|---|
| author | Yusuf, I. Guimond, D. Naiman, Z. Schiff, T. Clemons, B. Paulson, B. Hou, K. Taylor Meadows, K. Rose, M. Carter, L. |
| author_facet | Yusuf, I. Guimond, D. Naiman, Z. Schiff, T. Clemons, B. Paulson, B. Hou, K. Taylor Meadows, K. Rose, M. Carter, L. |
| author_sort | Yusuf, I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430246 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94302462022-08-31 P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES Yusuf, I. Guimond, D. Naiman, Z. Schiff, T. Clemons, B. Paulson, B. Hou, K. Taylor Meadows, K. Rose, M. Carter, L. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430246/ http://dx.doi.org/10.1097/01.HS9.0000847852.69497.6d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Yusuf, I. Guimond, D. Naiman, Z. Schiff, T. Clemons, B. Paulson, B. Hou, K. Taylor Meadows, K. Rose, M. Carter, L. P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES |
| title | P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES |
| title_full | P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES |
| title_fullStr | P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES |
| title_full_unstemmed | P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES |
| title_short | P1247: GB5121 IS A NOVEL, IRREVERSIBLE, COVALENT BTK INHIBITOR WITH HIGH SELECTIVITY AND CNS-PENETRANCE FOR TREATMENT OF CNS MALIGNANCIES |
| title_sort | p1247: gb5121 is a novel, irreversible, covalent btk inhibitor with high selectivity and cns-penetrance for treatment of cns malignancies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430246/ http://dx.doi.org/10.1097/01.HS9.0000847852.69497.6d |
| work_keys_str_mv | AT yusufi p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT guimondd p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT naimanz p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT schifft p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT clemonsb p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT paulsonb p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT houk p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT taylormeadowsk p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT rosem p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies AT carterl p1247gb5121isanovelirreversiblecovalentbtkinhibitorwithhighselectivityandcnspenetrancefortreatmentofcnsmalignancies |